Mr Manusu has over 25 years experience running biotechnology companies worldwide. He has been involved in the development of the PrIME technology since its invention in 1985. Mr Manusu was also involved in the US plasma collection business creating, along with Dr Nair, the then world’s largest independent plasma collection organisation. This business collected both normal and specialty plasmas, including hyperimmunes for the US Government bioterrorism program. Throughout this period he has undertaken a number of significant cross border restructures, mergers, acquisitions and divestures. Finally, Mr Manusu has raised over $200 million in public funding and government R&D grants including $2.8m for NuSep in 2013 and $18m for PrIME Biologics in 2014. Mr Manusu has a degree in Commerce and is a Fellow of the Financial Services Institute of Australasia. Mr Manusu has worked in the Australian, Asian and U.S. Biotechnology markets and is best described as a biotechnology entrepreneur.